• Claim your 1.0h CE/CME Credit Here

  • What best describes your title?*
  • If MD/DO
  • If RN/NP
  • If PharmD
  • Where are you based?
  • How did you FIRST hear about our tweetorials?
  • 1. In PAH, NO is primarily used in the following:*
  • 2.  Large multicenter clinical trials with riociguat are supporting the inclusion of the drug in the treatment algorithm of PAH. In which specific setting?*
  • 3.  Which of the following pathways are targeted by approved therapies for patients with PAH?*
  • 4. Did you follow the entire tweetorial?*
  • 5. Did you find this to be an effective learning tool?*
  • 7. How will the program change your practice?*
  • 8. Will you recommend @pulmmed_ce and/or this website to your colleagues?*
  •  - -
    2 digit month, 2 digit day, 4 digit year
  • Should be Empty: